Mindful Attention Training for Pediatric Cancer Survivors
Trial Summary
What is the purpose of this trial?
This pilot study will evaluate the cognitive and behavioral outcomes of using a novel, adaptive attention training in pediatric cancer survivors.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on cancer-related treatments, it will be discussed with the study team to see if it affects your participation.
What data supports the effectiveness of the treatment Mindful Attention Training for Pediatric Cancer Survivors?
Research shows that attention training can help improve attention in children who have survived cancer, with studies indicating improvements in attention measures. A cognitive remediation program for cancer survivors showed significant improvement in attention, suggesting that similar attention-focused treatments could be beneficial.12345
Is Mindful Attention Training safe for children, including those who have survived cancer?
How is Novel Mindful Attention Training different from other treatments for pediatric cancer survivors?
Novel Mindful Attention Training is unique because it focuses on improving attention and cognitive functions through mindfulness techniques, which is different from traditional treatments that may not specifically target attention issues. This approach is particularly relevant for pediatric cancer survivors who often experience attention problems due to their illness or treatment.34689
Research Team
Joaquin Anguera, PhD
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for children aged 7-17 who have survived pediatric cancer, can follow the study's procedures, and have a guardian to consent. They should speak English fluently, not be on certain cancer treatments that affect participation, and must have had radiation therapy to the brain or neck.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete adaptive attention training ('Engage') for 6-8 weeks, with randomized cohorts completing either 15 hours or 1 hour of training.
Follow-up
Participants are monitored for cognitive and behavioral outcomes after completing the training.
No Contact Group Assessment
Participants in the no-contact group complete baseline and end-of-study assessments to evaluate assessment feasibility and reliability.
Treatment Details
Interventions
- Novel Mindful Attention Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor